FC Association 1893 Hamburg

Florida Cancer Specialists & Research Institute Studies Offer Innovative New Findings in the Diagnosis and Treatment of Gastrointestinal and Genitourinary Cancers at Global Symposium

Retrieved on: 
Vendredi, février 24, 2023
FACP, Rectum, University of Florida Cancer and Genetics Research Complex, FCS, Cancer, Colon, Diagnosis, Research, Gastrointestinal cancer, FC Association 1893 Hamburg, Patient, Stomach, Liver, KRAS, Growth, Kidney, Pancreas, GU, Health, Drug development, GI, Gallbladder, Society, Cholangiocarcinoma, ASCO, Science, Woman, American Society of Clinical Oncology, Education, Prostate, Pharmaceutical industry, Medical imaging, Nursing, MD

Clinicians and researchers from around the globe came together at the two symposiums to share the latest science and approaches in GI and GU cancer treatment, research and care.

Key Points: 
  • Clinicians and researchers from around the globe came together at the two symposiums to share the latest science and approaches in GI and GU cancer treatment, research and care.
  • Genitourinary cancers, including kidney and bladder cancers, occur in the urinary system of men and women and in the reproductive organs in men, such as prostate and testicular cancers.
  • Gastrointestinal cancers affect the digestive tract organs, such as the stomach, large and small intestine, pancreas, colon, liver, rectum, anus and biliary system.
  • Through research, education, and promotion of high quality and equitable patient care, ASCO works to conquer cancer.

Florida Cancer Specialists & Research Institute Contributing to Rapid Advancements in Breast Cancer Treatment

Retrieved on: 
Mardi, décembre 13, 2022
Breast cancer, Epidermal growth factor, Woman, Immunotherapy, Drug development, U.S. News & World Report, Physician, Stanford University, FACP, VELA, Health, University of Florida Cancer and Genetics Research Complex, 2021 Essex County Council election, Cancer, ASCO, Memorial Sloan Kettering Cancer Center, Fulvestrant, Paclitaxel, Knowledge, News, Recurrence, SERD, CCNE1, MD, FCS, Risk, Monroe Dunaway Anderson, Harvard University, Trastuzumab, American Society of Clinical Oncology, FC Association 1893 Hamburg, Research, Society, RSK, Duke, CDK, Patient, PFS, Medical imaging, Pharmaceutical industry, Birth control

Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) hematologists and medical oncologists were contributors to several presentations at the San Antonio Breast Cancer Symposium® (SABCS) this past week, sharing the findings of state-of-the-art breast cancer research conducted at FCS.

Key Points: 
  • Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) hematologists and medical oncologists were contributors to several presentations at the San Antonio Breast Cancer Symposium® (SABCS) this past week, sharing the findings of state-of-the-art breast cancer research conducted at FCS.
  • Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.
  • Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy.

FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE ON THE FOREFRONT OF IMMUNOTHERAPHY TREATMENT ADVANCEMENTS FOR CANCER PATIENTS

Cytokine release syndrome, LLC, ASCO, University of Florida Cancer and Genetics Research Complex, Cancer, SMH, GLOBE, Immunotherapy, Sarasota Memorial Hospital, Immune system, Collection, Physician, Society, Hope, American Society of Clinical Oncology, Time, FCS, Health, CRS, FC Association 1893 Hamburg, Patient, Drug development, U.S. News & World Report, News, Bispecific monoclonal antibody, MD, Medicine, Vaccine, Pharmaceutical industry

Immunotherapy treatment uses certain components of a persons own immune system to fight cancer by changing or improving how the immune system works.

Key Points: 
  • Immunotherapy treatment uses certain components of a persons own immune system to fight cancer by changing or improving how the immune system works.
  • These artificial proteins bind to cancer cells and enhance the immune systems response to fight cancer.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.